Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.

Article  PubMed  Google Scholar 

Wang L, Lu B, He M, Wang Y, Wang Z, Du L. Prostate cancer incidence and mortality: global status and temporal trends in 89 countries from 2000 to 2019. Front Public Health. 2022;10:811044. https://doi.org/10.3389/fpubh.2022.811044.

Article  PubMed  PubMed Central  Google Scholar 

Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17–48. https://doi.org/10.3322/caac.21763.

Article  PubMed  Google Scholar 

Chang WH, Lee CC, Yen YH, Chen HL. Oxidative damage in patients with benign prostatic hyperplasia and prostate cancer co-exposed to phthalates and to trace elements. Environ Int. 2018;121(2):1179–84. https://doi.org/10.1016/j.envint.2018.10.034.

Article  CAS  PubMed  Google Scholar 

Zaichick V, Zaichick S. Significance of trace element quantities in the prostatic secretion of patients with benign prostatic hyperplasia and prostate cancer. J Cancer Metastasis Treat. 2019;5:48. https://doi.org/10.20517/2394-4722.2019.07.

Article  CAS  Google Scholar 

Bostwick DG. Grading prostate cancer. Am J Clin Pathol. 1994;102:S38–56.

CAS  PubMed  Google Scholar 

Pizent A, Andelkovic M, Lovakovic BT, Semren TZ, Djordjevic AB, Gamulin M. Environmental exposure to metals, parameters of oxidative stress in blood and prostate cancer: results from two cohorts. Antioxidants. 2022;11(10):2044. https://doi.org/10.3390/antiox11102044.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chandrasekaran B, Dahiya NR, Tyagi A, Kolluru V, Saran U, Baby BV. Chronic exposure to cadmium induces a malignant transformation of benign prostate epithelial cells. Oncogenesis. 2020;9:23. https://doi.org/10.1038/s41389-020-0202-7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rawla P. Epidemiology of prostate cancer. World J Oncol. 2019;10(2):63–8. https://doi.org/10.14740/wjon1191.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vella V, Malaguarnera R, Lappano R, Maggiolini M, Belfiore A. Recent views of heavy metals as possible risk factors and potential preventive and therapeutic agents in prostate cancer. Mol Cell Endocrinol. 2017;457:57–72. https://doi.org/10.1016/j.mce.2016.10.020.

Article  CAS  PubMed  Google Scholar 

Lim KB. Epidemiology of clinical benign prostatic hyperplasia. Asian J Urol. 2017;4(3):148–51. https://doi.org/10.1016/j.ajur.2017.06.004.

Article  PubMed  PubMed Central  Google Scholar 

Wu H, Wang M, Raman JD, McDonald AC. Association between urinary arsenic, blood cadmium, blood lead, and blood mercury levels and serum prostate-specific antigen in a population-based cohort of men in the United States. PLoS One. 2021;16(4):e0250744. https://doi.org/10.1371/journal.pone.0250744.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wijngaarden EV, Singer EA, Palapattu GS. Prostate-specific antigen levels in relation to cadmium exposure and zinc intake: results from the 2001–2002 national health and nutrition examination survey. Prostate. 2008;68:122–8. https://doi.org/10.1002/pros.20668.

Article  CAS  PubMed  Google Scholar 

Qayyum MA, Zahid F, Yaseen M, Mahmood MHR, Irfan A, Zafar MN. Statistical assessment of toxic and essential metals in the serum of female patients with lung carcinoma from Pakistan. Biol Trace Elem Res. 2020;197:367–83. https://doi.org/10.1007/s12011-019-01998-8.

Article  CAS  PubMed  Google Scholar 

Mahmood MHR, Qayyum MA, Yaseen F, Farooq T, Farooq Z, Yaseen M, et al. Multivariate investigation of toxic and essential metals in the serum from various types and stages of colorectal cancer patients. Biol Trace Elem Res. 2022;200(1):31–48. https://doi.org/10.1007/s12011-021-02632-2.

Article  CAS  PubMed  Google Scholar 

Karunasinghe N, Minas TZ, Bao BY, Lee A, Wang A, Zhu S, et al. Assessment of factors associated with PSA level in prostate cancer cases and controls from three geographical regions. Sci Rep. 2022;12:55. https://doi.org/10.1038/s41598-021-04116-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu CC, Pu YS, Wu HC, Yang CY, Chen YC. Reversed association between levels of prostate specific antigen and levels of blood cadmium and urinary cadmium. Chemosphere. 2011;83:1188–91. https://doi.org/10.1016/j.chemosphere.2010.12.085.

Article  CAS  PubMed  Google Scholar 

StatSoft STATISTICA for Windows. Computer Program Manual, StatSoft, Tusla; 1999.

Jolliffe I. Principal component analysis. Berlin: Springer; 2011.

Google Scholar 

Jolliffe I. Principal component analysis. 2nd ed. New York: Springer; 2002.

Google Scholar 

Everitt BS, Landau S, Leese M, Stahl D. Cluster analysis. 5th ed. Chichester: John Wiley & Sons; 2011.

Book  Google Scholar 

Ren Y, Zhang Z, Ren Y, Li W, Wang M, Xu G. Diagnosis of lung cancer based on metal contents in serum and hair using multivariate statistical methods. Talanta. 1997;44(10):1823–31. https://doi.org/10.1016/S0039-9140(97)00062-3.

Article  CAS  PubMed  Google Scholar 

Saleh SAK, Adly HM, Abdelkhaliq AA, Nassir AM. Serum levels of selenium, zinc, copper, manganese, and iron in prostate cancer patient. Curr Urol. 2020;14:44–9. https://doi.org/10.1159/000499261.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Platz EA, Helzlsouer KJ. Selenium, zinc, and prostate cancer. Epidemiol Rev. 2001;23:93–101. https://doi.org/10.1093/oxfordjournals.epirev.a000801.

Article  CAS  PubMed  Google Scholar 

Genchi G, Sinicropi MS, Lauria G, Carocci A, Catalano A. The effects of cadmium toxicity. Int J Environ Res Public Health. 2020;17:3782. https://doi.org/10.3390/ijerph17113782.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hartwig A. Cadmium and cancer. In: Sigel A, Sigel H, Sigel RKO, editors. Cadmium: from toxicity to essentiality. Metal ions in life sciences, vol. 11. Dordrecht: Springer; 2013. p. 491–507. https://doi.org/10.1007/978-94-007-5179-8_15.

Chapter  Google Scholar 

Zimta AA, Schitcu V, Gurzau E, Stavaru C, Manda G, Szedlacsek S, Berindan-Neagoe I. Biological and molecular modifications induced by cadmium and arsenic during breast and prostate cancer development. Environ Res. 2019;178:108700. https://doi.org/10.1016/j.envres.2019.108700.

Article  CAS  PubMed  Google Scholar 

Nordberg GF, Nogawa K, Nordberg M. In: Nordberg GF, Fowler GF, Nordberg M, editors. Handbook on the toxicology of metals, cadmium. 4th ed. Amsterdam: Elsevier; 2015. pp. 667–716.

Zhang L, Zhu Y, Hao R, Shao M, Luo Y. Cadmium levels in tissue and plasma as a risk factor for prostate carcinoma: a meta-analysis. Biol Trace Elem Res. 2016;172:86–92. https://doi.org/10.1007/s12011-015-0576-0.

Article  CAS  PubMed  Google Scholar 

Ju-Kun S, Yuan DB, Rao HF, Chen TF, Luan BS, Xu XM, et al. Association between cd exposure and risk of prostate cancer: a prisma-compliant systematic review and meta-analysis. Medicine. 2016;95:e2708. https://doi.org/10.1097/MD.0000000000002708.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martinez VD, Vucic EA, Becker-Santos DD, Gil L, Lam WL. Arsenic exposure and the induction of human cancers. J Toxicol. 2011;431287:13. https://doi.org/10.1155/2011/431287.

Article  CAS  Google Scholar 

Ren X, McHale CM, Skibola CF, Smith AH, Smith MT, Zhang L. An emerging role for epigenetic dysregulation in arsenic toxicity and carcinogenesis. Environ Health Perspect. 2011;119(1):11–9. https://doi.org/10.1289/ehp.1002114.

Article  CAS  PubMed  Google Scholar 

Wakwe C, Odum EP, Amadi C. The impact of plasma zinc status on the severity of prostate cancer disease victor C. Investig Clin Urol. 2019;60:162–8. https://doi.org/10.4111/icu.2019.60.3.162.

Article  PubMed  PubMed Central  Google Scholar 

Liang JY, Liu YY, Zou J, Franklin RB, Costello LC, Feng P. Inhibitory effect of zinc on human prostatic carcinoma cell growth. Prostate. 1999;40:200–7. https://doi.org/10.1002/(SICI)1097-0045(19990801)40:33.0.CO;2-3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Costello LC, Franklin RB. Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer. Prostate. 1998;35:285–96. https://doi.org/10.1002/(sici)1097-0045(19980601)35:4%3c285:aid-pros8%3e3.0.co;2-f.

Article  CAS  PubMed  Google Scholar 

Karunasinghe N. Zinc in prostate health and disease: a mini review. Biomedicines. 2022;10:3206. https://doi.org/10.3390/biomedicines10123206.

Article  CAS  PubMed  PubMed Central